Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia
Mood disorders and schizophrenia are common and complex disorders with consistent evidence of genetic and environmental influences on predisposition. It is generally believed that the consequences of disease, gene expression, and allelic heterogeneity may be partly the explanation for the variabilit...
Main Authors: | Firoza Mamdani, Maureen V. Martin, Todd Lencz, Brandi Rollins, Delbert G. Robinson, Emily A. Moon, Anil K. Malhotra, Marquis P. Vawter |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2013/748095 |
Similar Items
-
The first decade and beyond of transcriptional profiling in schizophrenia
by: P. Adolfo Sequeira, et al.
Published: (2012-01-01) -
A genomic investigation of major depressive disorder and antidepressant response
by: Mamdani, Firoza
Published: (2012) -
Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.
by: Brandi Rollins, et al.
Published: (2009-01-01) -
Exosomal Long NonCoding Rnas as Cancer Biomarkers and Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2020-01-01) -
A Role for Noncoding Variation in Schizophrenia
by: Panos Roussos, et al.
Published: (2014-11-01)